Ifosfamide and Pyogenic liver abscess - a phase IV clinical study of FDA data

Summary:

Pyogenic liver abscess is reported as a side effect among people who take Ifosfamide (ifosfamide), especially for people who are male, 20-29 old, have been taking the drug for 1 - 6 months also take Bendamustine, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Pyogenic liver abscess when taking Ifosfamide. It is created by eHealthMe based on reports of 21,274 people who have side effects when taking Ifosfamide from the FDA, and is updated regularly.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

What is Pyogenic liver abscess?

Pyogenic liver abscess (liver abscess caused by bacteria) is found to be associated with 403 drugs and 968 conditions by eHealthMe. Check the latest studies of Pyogenic liver abscess.

On Jul, 14, 2026

21,274 people reported to have side effects when taking Ifosfamide.
Among them, 13 people (0.06%) have Pyogenic liver abscess.

Could Ifosfamide cause Pyogenic liver abscess?

Among these 13 people:

How long have people been on Ifosfamide when they have Pyogenic liver abscess? *

What is the gender of people who have Pyogenic liver abscess when taking Ifosfamide? *

female: 10 %
male: 90 %

What is the age of people who have Pyogenic liver abscess when taking Ifosfamide? *

What are other drugs people take besides Ifosfamide? *

What are other side effects people have besides Pyogenic liver abscess? *

Bacteraemia (presence of bacteria in the blood): 12 people, 92.31%
Liver Disorder (liver diseases): 12 people, 92.31%
Disease Progression: 11 people, 84.62%
Drug Ineffective: 11 people, 84.62%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
Bile Duct Stenosis (abnormal narrowing of the common bile duct): 1 person, 7.69%
Cholangitis Acute (rapid infection of bile duct): 1 person, 7.69%
Cytomegalovirus Infection: 1 person, 7.69%
Enterococcal Infection: 1 person, 7.69%
Urinary Tract Disorder: 1 person, 7.69%

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 11 people, 84.62%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Ifosfamide and have Pyogenic liver abscess?

- Check whether Pyogenic liver abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ifosfamide:

Ifosfamide (21,285 reports)

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (403 drugs)

Browse all the conditions that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifosfamide) and Ifosfamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.